2024-03-012025-02-282025-02-28false05352733PODIATRY FIRST LTD2025-11-1986900falseiso4217:GBPxbrli:pure053527332024-02-29053527332025-02-28053527332024-03-012025-02-28053527332023-02-28053527332024-02-29053527332023-03-012024-02-2905352733bus:SmallEntities2024-03-012025-02-2805352733bus:AuditExempt-NoAccountantsReport2024-03-012025-02-2805352733bus:FullAccounts2024-03-012025-02-2805352733bus:PrivateLimitedCompanyLtd2024-03-012025-02-2805352733core:WithinOneYear2025-02-2805352733core:AfterOneYear2025-02-2805352733core:WithinOneYear2024-02-2905352733core:AfterOneYear2024-02-2905352733core:ShareCapital2025-02-2805352733core:SharePremium2025-02-2805352733core:RevaluationReserve2025-02-2805352733core:OtherReservesSubtotal2025-02-2805352733core:RetainedEarningsAccumulatedLosses2025-02-2805352733core:ShareCapital2024-02-2905352733core:SharePremium2024-02-2905352733core:RevaluationReserve2024-02-2905352733core:OtherReservesSubtotal2024-02-2905352733core:RetainedEarningsAccumulatedLosses2024-02-2905352733core:LandBuildings2025-02-2805352733core:PlantMachinery2025-02-2805352733core:Vehicles2025-02-2805352733core:FurnitureFittings2025-02-2805352733core:OfficeEquipment2025-02-2805352733core:NetGoodwill2025-02-2805352733core:IntangibleAssetsOtherThanGoodwill2025-02-2805352733core:ListedExchangeTraded2025-02-2805352733core:UnlistedNon-exchangeTraded2025-02-2805352733core:LandBuildings2024-02-2905352733core:PlantMachinery2024-02-2905352733core:Vehicles2024-02-2905352733core:FurnitureFittings2024-02-2905352733core:OfficeEquipment2024-02-2905352733core:NetGoodwill2024-02-2905352733core:IntangibleAssetsOtherThanGoodwill2024-02-2905352733core:ListedExchangeTraded2024-02-2905352733core:UnlistedNon-exchangeTraded2024-02-2905352733core:LandBuildings2024-03-012025-02-2805352733core:PlantMachinery2024-03-012025-02-2805352733core:Vehicles2024-03-012025-02-2805352733core:FurnitureFittings2024-03-012025-02-2805352733core:OfficeEquipment2024-03-012025-02-2805352733core:NetGoodwill2024-03-012025-02-2805352733core:IntangibleAssetsOtherThanGoodwill2024-03-012025-02-2805352733core:ListedExchangeTraded2024-03-012025-02-2805352733core:UnlistedNon-exchangeTraded2024-03-012025-02-2805352733core:MoreThanFiveYears2024-03-012025-02-2805352733core:Non-currentFinancialInstruments2025-02-2805352733core:Non-currentFinancialInstruments2024-02-2905352733dpl:CostSales2024-03-012025-02-2805352733dpl:DistributionCosts2024-03-012025-02-2805352733core:LandBuildings2024-03-012025-02-2805352733core:PlantMachinery2024-03-012025-02-2805352733core:Vehicles2024-03-012025-02-2805352733core:FurnitureFittings2024-03-012025-02-2805352733core:OfficeEquipment2024-03-012025-02-2805352733dpl:AdministrativeExpenses2024-03-012025-02-2805352733core:NetGoodwill2024-03-012025-02-2805352733core:IntangibleAssetsOtherThanGoodwill2024-03-012025-02-2805352733dpl:GroupUndertakings2024-03-012025-02-2805352733dpl:ParticipatingInterests2024-03-012025-02-2805352733dpl:GroupUndertakingscore:ListedExchangeTraded2024-03-012025-02-2805352733core:ListedExchangeTraded2024-03-012025-02-2805352733dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-03-012025-02-2805352733core:UnlistedNon-exchangeTraded2024-03-012025-02-2805352733dpl:CostSales2023-03-012024-02-2905352733dpl:DistributionCosts2023-03-012024-02-2905352733core:LandBuildings2023-03-012024-02-2905352733core:PlantMachinery2023-03-012024-02-2905352733core:Vehicles2023-03-012024-02-2905352733core:FurnitureFittings2023-03-012024-02-2905352733core:OfficeEquipment2023-03-012024-02-2905352733dpl:AdministrativeExpenses2023-03-012024-02-2905352733core:NetGoodwill2023-03-012024-02-2905352733core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2905352733dpl:GroupUndertakings2023-03-012024-02-2905352733dpl:ParticipatingInterests2023-03-012024-02-2905352733dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-012024-02-2905352733core:ListedExchangeTraded2023-03-012024-02-2905352733dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-012024-02-2905352733core:UnlistedNon-exchangeTraded2023-03-012024-02-2905352733core:NetGoodwill2025-02-2805352733core:IntangibleAssetsOtherThanGoodwill2025-02-2805352733core:LandBuildings2025-02-2805352733core:PlantMachinery2025-02-2805352733core:Vehicles2025-02-2805352733core:FurnitureFittings2025-02-2805352733core:OfficeEquipment2025-02-2805352733core:AfterOneYear2025-02-2805352733core:WithinOneYear2025-02-2805352733core:ListedExchangeTraded2025-02-2805352733core:UnlistedNon-exchangeTraded2025-02-2805352733core:ShareCapital2025-02-2805352733core:SharePremium2025-02-2805352733core:RevaluationReserve2025-02-2805352733core:OtherReservesSubtotal2025-02-2805352733core:RetainedEarningsAccumulatedLosses2025-02-2805352733core:NetGoodwill2024-02-2905352733core:IntangibleAssetsOtherThanGoodwill2024-02-2905352733core:LandBuildings2024-02-2905352733core:PlantMachinery2024-02-2905352733core:Vehicles2024-02-2905352733core:FurnitureFittings2024-02-2905352733core:OfficeEquipment2024-02-2905352733core:AfterOneYear2024-02-2905352733core:WithinOneYear2024-02-2905352733core:ListedExchangeTraded2024-02-2905352733core:UnlistedNon-exchangeTraded2024-02-2905352733core:ShareCapital2024-02-2905352733core:SharePremium2024-02-2905352733core:RevaluationReserve2024-02-2905352733core:OtherReservesSubtotal2024-02-2905352733core:RetainedEarningsAccumulatedLosses2024-02-2905352733core:NetGoodwill2023-02-2805352733core:IntangibleAssetsOtherThanGoodwill2023-02-2805352733core:LandBuildings2023-02-2805352733core:PlantMachinery2023-02-2805352733core:Vehicles2023-02-2805352733core:FurnitureFittings2023-02-2805352733core:OfficeEquipment2023-02-2805352733core:AfterOneYear2023-02-2805352733core:WithinOneYear2023-02-2805352733core:ListedExchangeTraded2023-02-2805352733core:UnlistedNon-exchangeTraded2023-02-2805352733core:ShareCapital2023-02-2805352733core:SharePremium2023-02-2805352733core:RevaluationReserve2023-02-2805352733core:OtherReservesSubtotal2023-02-2805352733core:RetainedEarningsAccumulatedLosses2023-02-2805352733core:AfterOneYear2024-03-012025-02-2805352733core:WithinOneYear2024-03-012025-02-2805352733core:Non-currentFinancialInstrumentscore:CostValuation2024-03-012025-02-2805352733core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-012025-02-2805352733core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-012025-02-2805352733core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-012025-02-2805352733core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-012025-02-2805352733core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-012025-02-2805352733core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-012025-02-2805352733core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-012025-02-2805352733core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-012025-02-2805352733core:Non-currentFinancialInstrumentscore:CostValuation2025-02-2805352733core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-02-2805352733core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-02-2805352733core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-02-2805352733core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-02-2805352733core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-02-2805352733core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-02-2805352733core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-02-2805352733core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-02-2805352733core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2905352733core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2905352733core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2905352733core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2905352733core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2905352733core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2905352733core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2905352733core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2905352733core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2905352733bus:Director12024-03-012025-02-28

PODIATRY FIRST LTD

Registered Number
05352733
(England and Wales)

Unaudited Financial Statements for the Year ended
28 February 2025

PODIATRY FIRST LTD
Company Information
for the year from 1 March 2024 to 28 February 2025

Director

S Afzal

Registered Address

41 District Road
Wembley
Middlesex
HA0 2LE

Registered Number

05352733 (England and Wales)
PODIATRY FIRST LTD
Balance Sheet as at
28 February 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets3237279
237279
Current assets
Debtors4123,028134,554
Cash at bank and on hand513506
123,541135,060
Creditors amounts falling due within one year5(120,307)(112,140)
Net current assets (liabilities)3,23422,920
Total assets less current liabilities3,47123,199
Creditors amounts falling due after one year6(2,874)(13,252)
Net assets5979,947
Capital and reserves
Called up share capital100100
Profit and loss account4979,847
Shareholders' funds5979,947
The financial statements were approved and authorised for issue by the Director on 19 November 2025, and are signed on its behalf by:
S Afzal
Director
Registered Company No. 05352733
PODIATRY FIRST LTD
Notes to the Financial Statements
for the year ended 28 February 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover represents the total invoice value of services for podiatry related activities.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Office Equipment15
2.Average number of employees

20252024
Average number of employees during the year33
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 March 245,4345,434
At 28 February 255,4345,434
Depreciation and impairment
At 01 March 245,1555,155
Charge for year4242
At 28 February 255,1975,197
Net book value
At 28 February 25237237
At 29 February 24279279
4.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables16,24227,687
Amounts owed by group undertakings106,786106,867
Total123,028134,554
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables12,86110,907
Bank borrowings and overdrafts31,08841,250
Taxation and social security59,00741,157
Other creditors12,55014,026
Accrued liabilities and deferred income4,8014,800
Total120,307112,140
6.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts2,87413,252
Total2,87413,252
7.Related party transactions
Amounts owed by group undertakings of £106,786 (2024: £106,867) relates to Podiatry First Group Ltd. This is the holding company.